Table 2. Hematological parameters and hemolytic profile in SCA patients according to hypertension.
| NORM | HTN | |
| alpha-thalassemia (%) | 44.4 | 41.9 |
| RBC (1012/L) | 2.7±0.5 | 3.0±0.7** |
| WBC (109/L) | 9.4±2.4 | 10.2±2.7 |
| PLT (109/L) | 384.8±118.8 | 412.2±140.6 |
| Hb (g/dL) | 8.1±1.2 | 8.8±1.3** |
| Hct (%) | 22.7±3.3 | 24.7±3.8** |
| MCV (fl) | 84.6±9.9 | 84.3±10.1 |
| MCHC (pg) | 30.3±3.8 | 30.1±3.8 |
| RET (%) | 217.8±74.8 | 233.1±73.7 |
| BIL mM | 61.2±39.1 | 56.2±45.9 |
| LDH (UI/L) | 510.5±148.3 | 472.1±157.2 |
| AST (UI/L) | 40.7±13.7 | 36.0±13.0 |
| Hemolytic component (relative unit) | 0.20±0.99 | −0.24±0.97* |
Means ± SD. NORM group, patients with blood pressure values below 120/70 mmHg; HTN group, patients with BP values >120/70 mmHg; RBC, red blood cell count; WBC, white blood cell count; PLT, platelet count; Hb, hemoglobin; Hct, hematocrit; MCV, mean cell volume; MCHC, mean corpuscular hemoglobin concentration; RET, reticulocytes; BIL, bilirubin; LDH, lactate dehydrogenase; AST, aspartate aminotransferase. Significant difference (*p<0.05; **p<0.01).